President Trump confirms that he is taking the anti-malarial drug hydroxychloroquine as a preventive action on coronavirus.
Hydroxychloroquine, a malaria drug touted by the the President is not the cure that the world is waiting according to the new study that was published last Thursday in the New England Journal of Medicine. The study funded by the National Institutes of Health and conducted by researchers at New York-Presbyterian Hospital and Columbia University Irving Medical Center in New York City. Consequently, 1, 376 patients were admitted at emergency room with symptoms of coronavirus.
The findings of the study didn’t appear to help nor harm from the decade-malaria drug. The new findings were released after the Food and Drug Administration warned the people against hydroxychloroquine to treat coronavirus.
The New York State Department of Health, in partnership with the University of Albany, is conducting an observational study of the effectiveness of the potential vaccine. They are tracking down the medical records of covid-19 patients who have been discharged.
Still, the medical specialists are still seeking other potential drugs that can kill the coronavirus. There are no FDA-approved treatments for Covid-19 and health officials hypothetically declared that vaccine will be produced 12 to 18 months at the earliest.